Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
SOC Telemed does not have enough data to calculate 3-Year RORE %.
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
SOC Telemed 3-Year RORE % Related Terms
SOC Telemed 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for SOC Telemed's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SOC Telemed 3-Year RORE % Chart
SOC Telemed Annual Data
Trend
Dec19
Dec20
Dec21
3-Year RORE %
0.00
0.00
0.00
SOC Telemed Semi-Annual Data
Dec19
Dec20
Dec21
3-Year RORE %
0.00
0.00
0.00
TLMDW vs PHCI, JYNT, TALK: 3-Year RORE % Comparison
For the Medical Care Facilities subindustry, SOC Telemed's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SOC Telemed 3-Year RORE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, SOC Telemed's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where SOC Telemed's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2021 and 3-year before.
SOC Telemed (TLMDW) has a 3-Year RORE % of 0.00 as of Dec. 2021. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on SOC Telemed and its competitors.
Is SOC Telemed's 3-Year RORE % too high?
SOC Telemed's current 3-Year RORE % is 0.00. Overall, SOC Telemed has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does SOC Telemed's 3-Year RORE % compare to PHCI and JYNT?
SOC Telemed's 3-Year RORE % of 0.00 can be compared against companies in the Healthcare Providers & Services industry. The industry median 3-Year RORE % is 0.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Healthcare Providers & Services company?
The median 3-Year RORE % among Healthcare Providers & Services companies is 0.47, based on 601 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on SOC Telemed and its competitors. For the Healthcare Providers & Services industry, the median 3-Year RORE % is 0.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SOC Telemed's current 3-Year RORE % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SOC Telemed stock overvalued right now?
SOC Telemed (TLMDW) has a current 3-Year RORE % of 0.00. The current 3-Year RORE % is 0.00. SOC Telemed's overall GF Score™ is 19/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For SOC Telemed (TLMDW), the current 3-Year RORE % is 0.00 as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
SOC Telemed Inc is a provider of acute care telemedicine services and technology to U.S. hospitals and healthcare systems based on number of clients. It provides technology enabled clinical solutions which include acute teleNeurology, telePsychiatry, and teleICU, and telePulmonology service. It supports specialty care, providing time-sensitive specialty care when patients are vulnerable and may not otherwise have access. Its solution was developed to support complex workflows in the acute care setting by integrating cloud-based software platform, Telemed IQ, with a panel of patient advocates and a network of clinical specialists to create a seamless, acute telemedicine solution.
19GF Score
Get the complete analysis for TLMDW
3-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TLMDW has been successfully added to your 
